0 Σχόλια
0 Μοιράστηκε
614 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
N,N'-Dicyclohexyl Carbodiimide (DCC) Market to Reach USD 68.44 Million by 2032 Driven by Peptide Synthesis DemandThe global N,N'-Dicyclohexyl Carbodiimide (DCC) market continues its steady expansion, currently valued at USD 43 million in 2023 with projections indicating growth to USD 68.44 million by 2032. This represents a compound annual growth rate (CAGR) of 5.30% during the forecast period, driven primarily by increasing demand in peptide synthesis and pharmaceutical applications across major...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Peptide and Oligonucleotide CDMO Market: Advancements in Synthesis and Manufacturing TechnologiesIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Peptide Synthesis Market: Growth Trends, Opportunities, and Future OutlookPolaris Market Research presents its latest market research report, titled “ Peptide Synthesis MarketSize, Share, Trends and Forecast, 2026–2034”. It is a comprehensive market research report analyzing the fast-evolving peptide synthesis market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and...0 Σχόλια 0 Μοιράστηκε 835 Views 0 Προεπισκόπηση
-
Peptide Synthesis Industry: Emerging OpportunitiesValued at USD 762.26 million in 2025, the peptide synthesis market is projected to reach USD 819.62 million in 2026 and USD 1,482.67 million by 2034, growing at a CAGR of 7.7% during the forecast period 2026–2034. Key players include Bachem Holding AG, Biotage, Creative Diagnostics, GenScript, Lonza, Merck KGaA, PolyPeptide Group, Puresynth Research Chemicals Pvt Ltd., Syngene...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση